Protective Effect of Intravenous Levocarnitine on Subsequent-Month Hospitalization Among Prevalent Hemodialysis Patients, 1998 to 2003

Because hemodialysis patients are hospitalized about 15 days yearly, the association of monthly levocarnitine regimen with lower hospitalization rate is clinically significant. The causality of this association must be confirmed by randomized clinical trials.